IDH1 and glioma: The lack of nestin/GFAP expression changes in human primary glioblastoma cells implicates no induction of cell differentiation by the treatments (Fig. 7a-c), although such responses have been described for 5-aza-dC in hypermethylated IDH1-mutant secondary gliomas [56].